Maurie Markman

Cancer information on the Internet: the impact of employing specific search engines and search strategies

Timothy M. Markman, Maurie Markman, 2005 .

Introduction to the New Section “Oncology and Informatics”

Paul Martin Putora, Maurie Markman, 2018, Oncology.

Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary

Maurie Markman, M. Markman, 2006, Expert opinion on pharmacotherapy.

Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse

Razelle Kurzrock, Maurie Markman, J. Jack Lee, 2010, Clinical Cancer Research.

Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers.

Maurie Markman, M. Markman, Robert J Kim, 2005, Gynecologic oncology.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

James Allison, Stephen Forman, Massimo Cristofanilli, 2015, Mayo Clinic proceedings.

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma

Maurie Markman, R. Ozols, D. Spriggs, 2009, Cancer.

An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactions

Maurie Markman, M. Markman, J. Belinson, 1999, Journal of Cancer Research and Clinical Oncology.

Ovarian cancer: screening, treatment, and followup.

Robert C. Bast, Robert W. Makuch, Alice S. Whittemore, 1995, NIH consensus statement.